• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Analysis of remobilization efficiency of etoposide combined with cytarabine and pegfilgrastim, with or without plerixafor, for multiple myeloma recurrence following autologous hematopoietic stem cell transplantation.

作者信息

Zhou Yanhan, Qian Honglan, Zheng Jifu, Lu Ying, Ye Peipei

机构信息

Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China.

Institute of Hematology, Ningbo University, Ningbo, Zhejiang, China.

出版信息

Clin Exp Med. 2025 Jul 14;25(1):247. doi: 10.1007/s10238-025-01784-y.

DOI:10.1007/s10238-025-01784-y
PMID:40658263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12259785/
Abstract
摘要

相似文献

1
Analysis of remobilization efficiency of etoposide combined with cytarabine and pegfilgrastim, with or without plerixafor, for multiple myeloma recurrence following autologous hematopoietic stem cell transplantation.依托泊苷联合阿糖胞苷及培非格司亭（无论是否联用普乐沙福）用于自体造血干细胞移植后多发性骨髓瘤复发的动员效率分析。
Clin Exp Med. 2025 Jul 14;25(1):247. doi: 10.1007/s10238-025-01784-y.
2
Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.在恶性淋巴瘤或多发性骨髓瘤患者中，在使用粒细胞集落刺激因子的基础上加用普乐沙福用于造血干细胞动员以进行自体移植。
Cochrane Database Syst Rev. 2015 Oct 20;2015(10):CD010615. doi: 10.1002/14651858.CD010615.pub2.
3
Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group.多发性骨髓瘤患者在前次自体造血干细胞移植后复发时的干细胞动员：波兰骨髓瘤研究组的一项多中心报告。
J Clin Apher. 2021 Jun;36(3):443-453. doi: 10.1002/jca.21885. Epub 2021 Feb 16.
4
Higher efficacy of Etoposide + Cytarabine Plus Pegfilgrastim in poorly mobilizing Multiple Myeloma and lymphoma Patients.培非格司亭联合依托泊苷+阿糖胞苷在动员效果不佳的多发性骨髓瘤和淋巴瘤患者中的疗效更高。
Cytotherapy. 2023 Aug;25(8):885-890. doi: 10.1016/j.jcyt.2023.04.014. Epub 2023 May 20.
5
Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation-A Multicenter Report by the Polish Myeloma Study Group.波兰骨髓瘤研究小组的多中心报告：不同剂量阿糖胞苷用于既往自体造血细胞移植后复发的浆细胞骨髓瘤患者的干细胞动员
Cancers (Basel). 2024 Jul 19;16(14):2588. doi: 10.3390/cancers16142588.
6
Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials.造血干细胞动员方案在血液系统恶性肿瘤患者中的疗效：一项随机对照试验的系统评价和网络荟萃分析。
Stem Cell Res Ther. 2022 Mar 22;13(1):123. doi: 10.1186/s13287-022-02802-6.
7
PEGylated Granulocyte Colony-Stimulating Factor and Plerixafor Enhance Autologous Stem and Progenitor Cell Mobilization and Transplantation in Pediatric Patients.聚乙二醇化粒细胞集落刺激因子和普乐沙福增强儿科患者自体干细胞和祖细胞的动员及移植
Stem Cells Dev. 2025 Feb;34(3-4):61-72. doi: 10.1089/scd.2024.0178. Epub 2025 Jan 16.
8
Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic malignancies.系统评价血液恶性肿瘤患者自体移植中造血干细胞动员策略的随机对照试验
Biol Blood Marrow Transplant. 2012 Aug;18(8):1191-203. doi: 10.1016/j.bbmt.2012.01.008. Epub 2012 Jan 16.
9
A systematic overview of chemotherapy effects in acute myeloid leukaemia.急性髓系白血病化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):231-52. doi: 10.1080/02841860151116321.
10
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 Institutes.达雷妥尤单抗（Dara）和来那度胺（Len）联合四联诱导疗法用于新诊断多发性骨髓瘤（NDMM）患者的干细胞动员效果：两家机构的真实世界经验
Clin Lymphoma Myeloma Leuk. 2025 Aug;25(8):e563-e569. doi: 10.1016/j.clml.2025.04.003. Epub 2025 Apr 11.

本文引用的文献

1
Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre study.依托泊苷联合阿糖胞苷和培非格司亭治疗动员不佳的多发性骨髓瘤和淋巴瘤患者：一项前瞻性多中心研究。
Br J Haematol. 2024 Jun;204(6):2342-2350. doi: 10.1111/bjh.19367. Epub 2024 Feb 23.
2
Higher efficacy of Etoposide + Cytarabine Plus Pegfilgrastim in poorly mobilizing Multiple Myeloma and lymphoma Patients.培非格司亭联合依托泊苷+阿糖胞苷在动员效果不佳的多发性骨髓瘤和淋巴瘤患者中的疗效更高。
Cytotherapy. 2023 Aug;25(8):885-890. doi: 10.1016/j.jcyt.2023.04.014. Epub 2023 May 20.
3
Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group.多发性骨髓瘤患者在前次自体造血干细胞移植后复发时的干细胞动员：波兰骨髓瘤研究组的一项多中心报告。
J Clin Apher. 2021 Jun;36(3):443-453. doi: 10.1002/jca.21885. Epub 2021 Feb 16.
4
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.美国血液与骨髓移植学会、欧洲血液与骨髓移植学会、血液与骨髓移植临床试验网络以及国际骨髓瘤工作组关于复发多发性骨髓瘤患者挽救性造血细胞移植的共识会议
Biol Blood Marrow Transplant. 2015 Dec;21(12):2039-2051. doi: 10.1016/j.bbmt.2015.09.016. Epub 2015 Sep 30.
5
Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells.培门冬酶联合粒细胞集落刺激因子动员造血干细胞在自体造血干细胞移植治疗多发性骨髓瘤患者中的应用。
Eur J Haematol. 2011 Jun;86(6):488-95. doi: 10.1111/j.1600-0609.2011.01605.x. Epub 2011 Apr 1.